November 2008

Health plans are evaluating whether to stop carving out drug benefits, disease management, and even behavioral health management

Martin Sipkoff

Expanded blood testing can reveal much about individuals’ health risks, but how should health plans decide on coverage?

Steven R. Peskin, MD, MBA

Once accused of milking the system, oncologists are now complaining that they are losing money on some drugs that they administer

John Carroll

Because readings in the clinic are unreliable and are a questionable guide to diagnosing and treating high blood pressure, self-monitoring deserves a look

Lola Butcher

The man credited with health care innovation at IBM warns against any overhaul that would make companies disinclined to participate


Though the legislation isn’t comprehensive and won’t be a burden, some health plans will need to scramble to build specialist provider networks
John Carroll
The increasing use of electronic records may lead the way toward access to diagnostic rationales and long-range patient treatment histories
Martin Sipkoff
Molina Healthcare of Michigan leans on education in effort to improve care for black men
Frank Diamond
Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2
Thomas Morrow, MD

Our most popular topics on